CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $91.41 +3.28%
EPS Growth %: +3.1%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
FUSE, INM, TRI, More
EPS Growth %: +3.1%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.19, $0.19 better than the analyst estimate of $1.00. Revenue for the quarter came in at $97.7 billion versus the consensus estimate of $96.97 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $5.75-$6.00, versus the consensus of $5.97.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- JELD-WEN Holding, Inc. (JELD) Tops Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
- UFP Technologies (UFPT) Tops Q3 EPS by 34c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
